Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a promising therapeutic option for people with arthritis and obesity or type 2 diabetes mellitus owing to their pleiotropic effects, including weight loss, improved survival and reduced risk of major cardiovascular and renal events
Discuss your refill schedule with your provider to align with dose progression and storage capacity
"Constipation from GLP-1s can be compounded by the fact that people are eating less," says Hamilton, "resulting often in less fiber consumption and less stool bulk overall." Many people also drink less fluid to avoid feeling overly full on GLP-1 medications, which can also lead to constipation
Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling
Too much alcohol can also prevent you from getting enough calories
27 Our findings indicate that after four weeks of WMSP treatment, there was a reduction in serum levels of inflammatory cytokines in CG-LSD rats